Table 1.

Patient demographics at baseline

Patient	Sex	GINA score	Age (years)	ICS dose	FEV1 (l)	FEV1 (% predicted)	Methacholine PC20 (mg ml−1)	OUCC ratio	EMUCC (nmol l−1)
1	M	I	57	0	3.3	87	8.00	117.99	187.37
2	F	I	63	0	1.84	90	1.64	64.66	157.52
4	M	II	50	0	2.60	73	2.55	126.88	155.90
6	F	I	21	0	4.38	90	1.74	52.32	165.69
7	F	I	20	800	3.57	105	0.22	92.94	564.87
8	F	I	60	100	2.47	94	0.43	543.85	762.77
9	F	I	31	800	2.78	105	0.74	65.05	79.09
10	F	I	51	0	2.71	93	0.11	104.09	129.59
11	F	I	22	200	3.18	105	0.49	61.02	84.76
12	F	I	22	200	3.16	109	2.33	73.10	234.00
13	M	II	57	0	1.98	61	0.04	216.54	331.49
14	F	I	61	800	1.79	98	2.22	134.90	290.42
15	M	I	21	0	4.61	96	4.23	116.73	50.62
16	M	I	25	400	5.11	114	8.00	52.48	72.31
17	M	II	31	500	2.11	65	0.60	47.06	88.53
21	M	I	41	500	2.26	91	0.28	83.82	142.94
22	F	I	45	800	2.90	97	2.59	82.47	140.59
Mean				200	2.98	92.52	0.85	95.49	162.18
(SEM)				(0–500)*	(0.23)	(3.55)	(0.34)†	(14.12)†	(28.52)†

^*Median (interquartile range).

^†Geometric mean and (standard error of geometric mean). ICS, beclomethasone dipropionate equivalent dose of inhaled corticosteroid; FEV₁, forced expiratory volume in 1 s; FEF_25%−75%, forced expiratory flow between 25% and 75%; OUCC, overnight urinary cortisol : creatinine ratio; EMUCC, early morning urinary cortisol : creatinine ratio.